Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Levered Free Cash Flow (FCF)

Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-18m a -40.18% increase of 7m year over year
  • Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-115m a 31.61% decrease of -37m year over year
  • Iovance Biotherapeutics Inc Annual Levered Free Cash Flow (FCF) for 2019 was $-96m a 39.06% decrease of -37m from 2018
  • Iovance Biotherapeutics Inc Annual Levered Free Cash Flow (FCF) for 2018 was $-58m a 27.43% decrease of -16m from 2017
  • Iovance Biotherapeutics Inc Annual Levered Free Cash Flow (FCF) for 2017 was $-42m a 79.59% decrease of -34m from 2016
Other Cash Flow Metrics:
  • Iovance Biotherapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-28m a 24.94% decrease of -7m year over year
View Chart On Koyfin

Quarterly IOVA Levered Free Cash Flow (FCF) Data

06/2020$-18m
03/2020$-35m
12/2019$-37m
09/2019$-25m
06/2019$-18m
03/2019$-16m
12/2018$-20m
09/2018$-16m
06/2018$-13m
03/2018$-9m

Annual IOVA Levered Free Cash Flow (FCF) Data

2019$-96m
2018$-58m
2017$-42m
2016$-9m
2015$-9m
2014$-6m
2013$13m
2012$-6m
2011$9m
2010$1m